Shifts in KDIGO CKD risk groups with empagliflozin: Reno-protection from SGLT2 inhibition across the spectrum of riskS. E. Inzucchi, B. Zinman,M. Mattheus, D. Steubl,A. P. Ofstad,C. WannerDIABETOLOGIA（2022）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
